These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26025459)

  • 41. Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.
    Prince HE; Seaton BL; Matud JL; Batterman HJ
    Clin Vaccine Immunol; 2015 Mar; 22(3):291-7. PubMed ID: 25540275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
    Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
    J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein.
    Bréhin AC; Rubrecht L; Navarro-Sanchez ME; Maréchal V; Frenkiel MP; Lapalud P; Laune D; Sall AA; Desprès P
    Virology; 2008 Feb; 371(1):185-95. PubMed ID: 17949772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays.
    Johnson BW; Goodman CH; Holloway K; de Salazar PM; Valadere AM; Drebot MA
    Am J Trop Med Hyg; 2016 Jul; 95(1):182-192. PubMed ID: 26976887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate.
    Saraswat S; Athmaram TN; Parida M; Agarwal A; Saha A; Dash PK
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004782. PubMed ID: 27399001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic Methods for CHIKV Based on Serological Tools.
    Gaibani P; Landini MP; Sambri V
    Methods Mol Biol; 2016; 1426():63-73. PubMed ID: 27233261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and phylogenetic evidence of chikungunya virus circulating in Assam, India.
    Dutta P; Khan SA; Hazarika NK; Chetry S
    Indian J Med Microbiol; 2017; 35(3):389-393. PubMed ID: 29063884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.
    Andrew A; Navien TN; Yeoh TS; Citartan M; Mangantig E; Sum MSH; Ch'ng ES; Tang TH
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010152. PubMed ID: 35120141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1).
    Gelanew T; Poole-Smith BK; Hunsperger E
    J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of monoclonal antibody based antigen capture ELISA to detect chikungunya virus antigen in mosquitoes.
    Hundekar SL; Thakare JP; Gokhale MD; Barde PV; Argade SV; Mourya DT
    Indian J Med Res; 2002 Apr; 115():144-8. PubMed ID: 12239836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Chikungunya Virus in Nepal.
    Pandey BD; Neupane B; Pandey K; Tun MM; Morita K
    Am J Trop Med Hyg; 2015 Oct; 93(4):697-700. PubMed ID: 26195462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.
    Kim YC; López-Camacho C; Garcia-Larragoiti N; Cano-Mendez A; Hernandez-Flores KG; Domínguez-Alemán CA; Mar MA; Vivanco-Cid H; Viveros-Sandoval ME; Reyes-Sandoval A
    Viruses; 2019 May; 11(5):. PubMed ID: 31052472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.
    Kashyap RS; Morey SH; Ramteke SS; Chandak NH; Parida M; Deshpande PS; Purohit HJ; Taori GM; Daginawala HF
    Clin Vaccine Immunol; 2010 Feb; 17(2):291-7. PubMed ID: 20007365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
    Fumagalli MJ; de Souza WM; Romeiro MF; de Souza Costa MC; Slhessarenko RD; Figueiredo LTM
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M.
    Theillet G; Martinez J; Steinbrugger C; Lavillette D; Coutard B; Papageorgiou N; Dalbon P; Leparc-Goffart I; Bedin F
    Virology; 2019 Mar; 529():195-204. PubMed ID: 30721816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.
    Kam YW; Lee WW; Simarmata D; Le Grand R; Tolou H; Merits A; Roques P; Ng LF
    PLoS One; 2014; 9(4):e95647. PubMed ID: 24755730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining anti-IgM and IgG immunoassays for comprehensive chikungunya virus diagnostic testing.
    Mendoza EJ; Robinson A; Dimitrova K; Mueller N; Holloway K; Makowski K; Wood H
    Zoonoses Public Health; 2019 Dec; 66(8):909-917. PubMed ID: 31449360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of in-house serological methods for diagnosis and surveillance of chikungunya.
    Galo SS; González K; Téllez Y; García N; Pérez L; Gresh L; Harris E; Balmaseda Á
    Rev Panam Salud Publica; 2017 Aug; 41():e56. PubMed ID: 28902269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.
    Ko YJ; Choi KS; Nah JJ; Paton DJ; Oem JK; Wilsden G; Kang SY; Jo NI; Lee JH; Kim JH; Lee HW; Park JM
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):922-9. PubMed ID: 16085909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.